Furthermore, considering our observed changes in cytokine secretion following RALA and RALB loss in the MDA-MB-468 model, future experiments utilizing immunocompetent mice are needed to examine the role of the RALs in regulating the host anti-tumor immune response. The gene discussed is RALA; the disease is neoplasm.